A new treatment which helps prevent people's cancer returning after they have had surgery to treat renal cell carcinoma has been recommended by NICE in final guidance published today.
Pembrolizumab could benefit up to 2,500 people.
Learn more: nice.org.uk/ta830?utm_medi #NICENews
Pinned Tweet
read image description
ALT
4
4





